경막하 전극 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of subdural electrodes Market

The global subdural electrodes market was valued at USD 48.84 million in 2025 and is projected to grow to USD 52.87 million in 2026. The market is expected to reach USD 105.43 million by 2034, registering a CAGR of 9.00% during the forecast period (2026-2034).

The United States dominated the global market in 2025, accounting for 39.96% of the total market share, supported by a high adoption rate of intracranial monitoring procedures and a strong presence of specialized epilepsy centers.

Subdural electrodes are medical devices used for intracranial monitoring in patients suffering from epilepsy and drug-resistant seizures. These devices help locate the origin of seizures during the pre-surgical phase of epilepsy treatment, enabling surgeons to perform accurate brain mapping and improve surgical outcomes.

Market Growth Drivers

Rising Prevalence of Epilepsy

The growing global burden of epilepsy is a key driver of market expansion. According to the World Health Organization (WHO), nearly 50 million people worldwide live with epilepsy, and approximately 5 million people are diagnosed annually. Around 30% of patients fail to achieve seizure control through anti-epileptic drugs (AEDs), increasing the demand for surgical interventions and intracranial monitoring.

As epilepsy surgeries rise globally, the adoption of subdural electrodes is expected to increase significantly between 2026 and 2034.

Increasing Intracranial Monitoring Procedures

The growing number of Level 3 and Level 4 epilepsy centers is contributing to higher procedural volumes. Intracranial monitoring allows detailed visualization of seizure focus, improving procedural success rates. The superior safety, precision, and patient comfort associated with depth electrodes further support product adoption.

Market Trends

Expansion of Clinical Applications

The market is witnessing increased research into newer applications beyond epilepsy. For instance, clinical trials initiated in France explored the use of cortical electrodes in patients with head trauma and brain lesions. Such pipeline studies are expected to broaden clinical applications and drive commercialization of innovative electrode technologies.

Additionally, advancements in robot-assisted placement of depth electrodes, particularly in Japan, are supporting market growth.

Market Restraints

Lack of Awareness in Emerging Economies

Despite the high prevalence of epilepsy in low- and middle-income countries, access to advanced surgical planning remains limited. WHO data indicates that nearly 75% of people with epilepsy in low-income countries do not receive adequate treatment. Limited infrastructure, social stigma, and lack of awareness about surgical solutions restrict the adoption of subdural electrodes in emerging regions.

Market Segmentation Analysis

By Material

The market is segmented into platinum and stainless steel.

• The platinum segment is projected to dominate with a 76.83% market share in 2026, driven by superior biocompatibility, better electrical conductivity, and lower infection risks.
• Stainless steel is expected to witness declining preference due to oxidation risks and higher infection rates.

By Type

The market includes strip, grid, depth, and others.

• The depth electrode segment is expected to lead with 63.39% market share in 2026, owing to minimal invasiveness, improved patient comfort, and enhanced deep brain structure recording.
• Strip and grid electrodes are projected to experience gradual decline due to the growing shift toward depth electrodes.

By End-User

The market is categorized into hospitals & ASCs, specialty clinics, and others.

• Hospitals and ASCs will account for 71.74% of the total market share in 2026, as most implantation procedures are performed in these settings.
• Specialty clinics are expected to grow steadily due to the rising number of accredited epilepsy centers globally.

Regional Insights

United States

The U.S. leads the global market, supported by strong adoption of intracranial monitoring and increasing drug-resistant epilepsy cases. The expansion of specialized epilepsy centers continues to strengthen regional dominance through 2034.

Europe

Europe is the second-leading region, driven by advanced healthcare facilities and higher adoption of depth electrodes. Approximately 18,000 craniotomies for epilepsy are performed annually in Europe, supporting steady demand.

Japan

Japan is projected to witness strong growth, supported by favorable reimbursement policies for robot-assisted electrode placement and increasing R&D initiatives.

Rest of the World

Countries such as China, India, Brazil, and South Africa are improving epilepsy surgical infrastructure, presenting future growth opportunities during the forecast period.

Key Industry Players

Major players operating in the market include:

• Integra LifeSciences Corporation
• Natus Medical Incorporated
• Ad-Tech Medical Instrument Corporation
• CorTec GmbH
• DIXI Medical
• PMT Corporation
• NIHON KOHDEN CORPORATION
• NeuroOne

Strategic partnerships, acquisitions, and product innovations remain key competitive strategies. For example, Natus Medical was acquired by ArchiMed in 2022, and NeuroOne received FDA clearance for its Evo sEEG Electrode.

Conclusion

The global subdural electrodes market is set to grow from USD 48.84 million in 2025 to USD 105.43 million by 2034, driven by the increasing prevalence of epilepsy, rising intracranial monitoring procedures, and technological advancements in depth electrode systems. While limited awareness in emerging markets poses challenges, expanding research initiatives and improved surgical infrastructure are expected to support sustained growth. With the U.S. maintaining leadership and Europe and Japan strengthening adoption, the market is positioned for steady expansion throughout the forecast period.

Segmentation By Material

• Platinum
• Stainless Steel

By Type

• Strip
• Grid
• Depth
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• U.S. (By Material, Type, and End-user)
• Europe (By Material, Type, and End-user)
• Japan (By Material, Type, and End-user)
• Rest of the World (By Material, Type, and End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Epilepsy, By Key Countries/Region, 2025
• 4.2. Key Industry Developments - Mergers, Acquisition, and Partnerships
• 4.3. New Product Launches, Approvals, and Recalls
• 4.4. Regulatory Scenario, By Key Countries/Region
• 4.5. Overview: Applications of Subdural Electrodes in Cranial Nerves & Others
• 4.6. Trends of Usage of Subdural Electrodes and Intracranial Monitoring in Epilepsy Surgery
• 4.7. Impact of COVID-19 on the Market

5. Global Subdural Electrodes Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Material
  • 5.1.1. Platinum
  • 5.1.2. Stainless Steel
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Strip
  • 5.2.2. Grid
  • 5.2.3. Depth
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. U.S.
  • 5.4.2. Europe
  • 5.4.3. Japan
  • 5.4.4. Rest of the World

6. U.S. Subdural Electrodes Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Material
  • 6.1.1. Platinum
  • 6.1.2. Stainless Steel
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Strip
  • 6.2.2. Grid
  • 6.2.3. Depth
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others

7. Europe Subdural Electrodes Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Material
  • 7.1.1. Platinum
  • 7.1.2. Stainless Steel
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Strip
  • 7.2.2. Grid
  • 7.2.3. Depth
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others

8. Japan Subdural Electrodes Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Material
  • 8.1.1. Platinum
  • 8.1.2. Stainless Steel
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Strip
  • 8.2.2. Grid
  • 8.2.3. Depth
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others

9. Rest of the World Subdural Electrodes Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Material
  • 9.1.1. Platinum
  • 9.1.2. Stainless Steel
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Strip
  • 9.2.2. Grid
  • 9.2.3. Depth
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. CorTec GmbH
    • 10.2.1.1. Overview
    • 10.2.1.2. Products & services
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. Ad-Tech Medical Instrument Corporation (ArchiMed)
    • 10.2.2.1. Overview
    • 10.2.2.2. Products & services
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. DIXI MEDICAL (Dixi)
    • 10.2.3.1. Overview
    • 10.2.3.2. Products & services
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. PMT Corporation
    • 10.2.4.1. Overview
    • 10.2.4.2. Products & services
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. inomed Medizintechnik GmbH
    • 10.2.5.1. Overview
    • 10.2.5.2. Products & services
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. Integra LifeSciences Corporation
    • 10.2.6.1. Overview
    • 10.2.6.2. Products & services
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Natus Medical Incorporated
    • 10.2.7.1. Overview
    • 10.2.7.2. Products & services
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)
  • 10.2.8. NIHON KOHDEN CORPORATION
    • 10.2.8.1. Overview
    • 10.2.8.2. Products & services
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. Financials (Based on Availability)
  • 10.2.9. NeuroOne
    • 10.2.9.1. Overview
    • 10.2.9.2. Products & services
    • 10.2.9.3. SWOT Analysis
    • 10.2.9.4. Recent Developments
    • 10.2.9.5. Strategies
    • 10.2.9.6. Financials (Based on Availability)
  • 10.2.10. Alliance Biomedica
    • 10.2.10.1. Overview
    • 10.2.10.2. Products & services
    • 10.2.10.3. SWOT Analysis
    • 10.2.10.4. Recent Developments
    • 10.2.10.5. Strategies
    • 10.2.10.6. Financials (Based on Availability)